Ekso Bionics, which develops exoskeletons for both industrial and medical uses, named Jack Glenn as its new chief financial officer on Aug. 13. (Also see "Market Intel: Exoskeletons Stretch Into Stroke And Mobility Rehab Markets To Ramp Up Growth " - Medtech Insight, 4 May, 2018.)
Glenn replaces Max Scheder-Bieschin, who has been with Ekso for eight years and is leaving the company. Glenn was previously the CFO for Sonendo and also served as CFO at...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?